“Outlawed” cure for chronic disease?

Big Pharma and their cronies in the mainstream medical establishment consider stem cells [Click here](1770d7/ct0_0/1/ms?sid=TV2%3Al9KuI3S4K) to view this message in your browser | [Click here](1770d7/l-002e/zout?sid=TV2%3Al9KuI3S4K) to stop receiving our messages [] [] Al Sears, MD 11905 Southern Blvd. Royal Palm Beach, FL 33411 [] July 18, 2023 [] Reader, Big Pharma and their cronies in the mainstream medical establishment consider stem cells to be a direct threat to their multibillion-dollar profit machine – and they’ll do anything and everything in their power to keep this regenerative therapy out of your hands... Until they can develop and sell a “stem cell” drug, of course. Sadly, the majority of traditionally trained doctors – as well-intentioned as most of them are – simply go along with the conventional “wisdom” presented to them by FDA-backed pharmaceutical companies. You see, over the past few years, powerful Big Pharma players — like Pfizer, Johnson & Johnson, Novartis, and Gilead Sciences — have been quietly snapping up stem cell companies in a rush to develop expensive “stem cell drugs,” which they can then patent. And the FDA has been with them every step of the way. For years, the agency that claims to “be responsible for advancing the public health”1 tried to block doctors like me from providing patients like you access to stem cells – even when the cells were coming from your own body. But finally, I feel a reason to be hopeful... Recently, a federal court ruling dealt a severe blow to the FDA’s ability to regulate and control stem cell therapies. If the FDA had prevailed, they would have been granted sweeping new authority over stem cell therapies. Because the FDA insists that these therapies are “unproven” and “dangerous.” But thanks to this ruling, stem cells have finally been recognized as a part of your own body. In other words, the agency’s defeat means that they won’t be able to regulate stem cells like they can Big Pharma’s drugs. And that’s great news for you. Because stem cell therapies have been proven to treat, slow down, and even regress: - Heart disease2 - Autoimmune diseases like rheumatoid arthritis, multiple sclerosis, and type 1 diabetes3,4 - Type 2 diabetes5 - Alzheimer’s and Parkinson’s diseases6,7 - Stroke and brain bleed8,9 - Bone, cartilage, ligament, and tendon damage As a regular reader, you’ve heard me say that stem cells are the future of medicine. They are your body’s raw material and they have the capacity to “self-renew” and regenerate any cell in your body like those that grow into tissues, organs, bones, skin, blood, and everything else. That means their healing potential is incalculable. I have no doubt that one day stem cells will be used to cure every disease. These days, therapy practitioners can extract stem cells easily from your own blood, fat, or bone marrow. Stem cell therapies also come with much less risk than conventional disease treatments, like Big Pharma meds or surgeries. Are you ready to put your pain behind you? Not long ago, I gave a lecture at the Sears Institute for Anti-Aging Medicine on the subject of stem cell therapy – and what it can do for you and your continued good health. This lecture was standing room only. But my staff captured it on film. I’d like to invite you to attend as well. To listen to this conversation in person, [please click this link](1770d7/ct1_0/1/lu?sid=TV2%3Al9KuI3S4K). To Your Good Health, Al Sears, MD, CNS --------------------------------------------------------------- References: - FDA. “What we do.” ~:text=FDA%20is%20responsible%20for%20advancing,maintain%20and%20improve%20their%20health. Accessed on July 11, 2023. - Wang L, et al. “Efficacy and safety of umbilical cord mesenchymal stem cell therapy for rheumatoid arthritis patients: a prospective phase I/II study.” Drug Des Devel Ther. 2019;13: 4331-4340. - Petrou P, et al. “Beneficial effects of autologous mesenchymal stem cell transplantation in active progressive multiple sclerosis.” Brain. 2020 December;143(12): 3574–358. - Carlsson P, et al. “Preserved β-cell function in type 1 diabetes by mesenchymal stromal cells.” Diabetes. 2015 Feb:64(2):587-92. - Zhang Y, et al. “The clinical efficacy and safety of stem cell therapy for diabetes mellitus: a systematic review and meta-analysis.” Aging Dis. 2020 Feb 1;11(1):141-153. - Liu Y, et al. (2019). “The therapeutic efficacy of mesenchymal stem cells for Alzheimer's disease: a systematic review and meta-analysis.” J Alzheimer’s Dis. 2019;68(1):111-126. - Staff N, et al. “Mesenchymal stromal cell therapies for neurodegenerative diseases.” Mayo Clin Proc. 2019 May; 94(5): 892–905. - Li W, et al. “Mesenchymal stem cell-based therapy for stroke: current understanding and challenges.” Front Cell Neurosci. 2021 Feb 9;15:628940. - Leu S, Lin YC, et al. “Adipose-derived mesenchymal stem cells markedly attenuate brain infarct size and improve neurological function in rats.” J Transl Med. 2010. 8:63. --------------------------------------------------------------- alsearsmd@send.alsearsmd.com [Preferences | Unsubscribe](1770d7/l-002e/zout?sid=TV2%3Al9KuI3S4K) 11905 Southern Blvd., Royal Palm Beach, Florida 33411, United States